China New Economy ETF

Posted on | by Leon Hinde

CNEW gives investors a portfolio of the most fundamentally sound companies in China having the best growth prospects in sectors making up ‘the New Economy’, namely technology, health care, consumer staples and consumer discretionary.

{AXW:CNEW) is now under Algo Engine buy conditions and we add this to our long-term model portfolio.

Pro Medicus – Buy

Posted on | by Leon Hinde

Pro Medicus is now under algo engine buy signals after rallying 40% from the original buy signal back in July.

The current retracement from $35 to $29 means investors should be watching the short-term momentum indicators for a turn higher and apply a stop loss on a break below support or a turn lower in the momentum indicators.

For more detail on the strategy, please call our office on 1300 614 002.

ASX – Algo Buy

Posted on | by Leon Hinde

The chart below shows the range where we will be watching for the short-term momentum indicators to turn higher.

The price action now sits at 50% retracement of the March to November range. We expect to see buying interest begin to rebuild.

China New Economy ETF

Posted on | by Leon Hinde

CNEW gives investors a portfolio of the most fundamentally sound companies in China having the best growth prospects in sectors making up ‘the New Economy’, namely technology, health care, consumer staples and consumer discretionary.

{AXW:CNEW) is now under Algo Engine buy conditions and we add this to our long-term model portfolio.

Pro Medicus – Buy

Posted on | by Leon Hinde

Pro Medicus is now under algo engine buy signals after rallying 40% from the original buy signal back in July.

The current retracement from $35 to $29 means investors should be watching the short-term momentum indicators for a turn higher and apply a stop loss on a break below support or a turn lower in the momentum indicators.

For more detail on the strategy, please call our office on 1300 614 002.

Transurban – Buy

Posted on | by Leon Hinde

Transurban switched to Algo Engine buy conditions on 30 October at $13.10. The stock has since rallied to $15.60 and has now retraced back 50% to find support at the current price of $14.00.

Investors should watch the short-term momentum indicators as we’re likely to see a pick up in buying interest, supported by an attractive defensive dividend yield.